19-50507682-C-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The ENST00000598418.6(JOSD2):c.164G>A(p.Arg55Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000123 in 1,611,776 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R55W) has been classified as Uncertain significance.
Frequency
Consequence
ENST00000598418.6 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
JOSD2 | NM_001270639.2 | c.164G>A | p.Arg55Gln | missense_variant | 3/5 | ENST00000598418.6 | NP_001257568.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
JOSD2 | ENST00000598418.6 | c.164G>A | p.Arg55Gln | missense_variant | 3/5 | 1 | NM_001270639.2 | ENSP00000468956 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000348 AC: 53AN: 152150Hom.: 0 Cov.: 30
GnomAD3 exomes AF: 0.000125 AC: 31AN: 248666Hom.: 0 AF XY: 0.000141 AC XY: 19AN XY: 134940
GnomAD4 exome AF: 0.000100 AC: 146AN: 1459508Hom.: 0 Cov.: 32 AF XY: 0.000102 AC XY: 74AN XY: 726060
GnomAD4 genome AF: 0.000348 AC: 53AN: 152268Hom.: 0 Cov.: 30 AF XY: 0.000363 AC XY: 27AN XY: 74456
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 05, 2024 | The c.164G>A (p.R55Q) alteration is located in exon 3 (coding exon 2) of the JOSD2 gene. This alteration results from a G to A substitution at nucleotide position 164, causing the arginine (R) at amino acid position 55 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at